We released the largest literature study for the severe ovarian hyperstimulation syndrome treatment (OHSS) at the international scientific journal Reproductive Biology and Endocrinology. This is a prospective observational study (observational cohort study) of 362 high risk for serious OHSS appearance women . The 11.3 % of women have experienced serious OHSS which was successfully dropped just a few days after the grant luteal GnRH competitor stage.
No woman had hospital admission. The OHSS is the most serious complication of in-vitro fertilisation programs , and until recently there was no treatment for the serious form of the syndrome, which often requires hospitalization. This method, designed by Dr Τrifonas Lainas and his ''Eugonia'' team, in collaboration with the University of Thessaloniki, is the only treatment of the established serious OHSS.
Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study. Lainas GT, Kolibianakis EM, Sfontouris IA, Zorzovilis IZ, Petsas GK, Tarlatzi TB, Tarlatzis BC, Lainas TG. Reprod Biol Endocrinol. 2012;10:69
See the publication here http://www.ncbi.nlm.nih.gov/pubmed/22938051
